Global X Scientific Beta US ETF (SCIU) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Global X Scientific Beta US ETF (SCIU) trades at $33.48. Global X Scientific Beta US ETF (SCIU) seeks to replicate the performance of the Scientific Beta United States Multi-Beta Multi-Strategy Four-Factor Equal Risk Contribution… Market cap: $26.4M, Sector: Financial services.
Price as of Aug 21, 2026 · Last analyzed: Mar 17, 2026Analyst Coverage for SCIU: SCIU does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates SCIU against Financial Services peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
Not enough scored data yet to form a council read on SCIU.
How is this calculated? →Global X Scientific Beta US ETF (SCIU) Financial Services Profile
Global X Scientific Beta US ETF (SCIU) aims to mirror the Scientific Beta United States Multi-Beta Multi-Strategy Four-Factor Equal Risk Contribution (ERC) Index, investing in approximately 500 U.S.-listed stocks chosen via a proprietary methodology, offering investors exposure to a multi-factor investment strategy within the U.S. equity market.
What Is the Investment Thesis for SCIU?
Global X Scientific Beta US ETF (SCIU), with a market capitalization of $26.4M and a beta of 1.01, offers exposure to a multi-factor investment strategy within the U.S. equity market. The fund's primary value driver is its ability to track the Scientific Beta United States Multi-Beta Multi-Strategy Four-Factor Equal Risk Contribution (ERC) Index, providing diversification across approximately 500 U.S.-listed stocks. A key growth catalyst is the increasing investor interest in factor-based investing and smart beta strategies. Potential risks include the performance of the underlying index and the potential for tracking error. The fund's success hinges on the continued efficacy of the EDHEC Risk Institute Asia Ltd.'s proprietary methodology in selecting and weighting stocks.
Based on FMP financials and quantitative analysis
SCIU Key Highlights
Market capitalization of $26.4M indicates a small-cap ETF.
- Beta of 1.01 suggests the fund's volatility is similar to the overall market.
- The fund invests at least 80% of its total assets in securities of the underlying index, ensuring close tracking.
- The underlying index comprises approximately 500 or less U.S. listed common stocks, providing diversification.
- The fund's investment strategy is based on a proprietary methodology developed by EDHEC Risk Institute Asia Ltd.
Who Are SCIU's Competitors?
SCIU is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CLIA Veridien Climate Action ETF | $18.61 | -0.19% | $25.4M | 44 |
| FOVL iShares Focused Value Factor ETF | $73.39 | +0.02% | $25.1M | 44 |
| IFLY Wedbush ETFMG Global Cloud Technology ETF | $27.21 | +0.46% | $25.1M | 44 |
| JHME John Hancock Multifactor Energy ETF | $34.55 | +0.11% | $25.2M | — |
| JHMT John Hancock Multifactor Technology ETF | $68.81 | +0.78% | $25.5M | 44 |
| BCG Binah Capital Group, Inc. | $1.40 | +0.72% | $23.5M | 78 |
| EEA The European Equity Fund, Inc. | $11.15 | -0.59% | $74.7M | 67 |
| ALTEX Firsthand Alternative Energy Fund | $12.93 | -1.90% | $8.98M | 82 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are SCIU's Key Strengths?
Diversified exposure to approximately 500 U.S.-listed stocks.
- Proprietary index methodology developed by EDHEC Risk Institute Asia Ltd.
- Competitive expense ratio.
- Established brand name (Global X).
What Are SCIU's Weaknesses?
Small market capitalization ($0.03 billion).
- Potential for tracking error between the fund's performance and the underlying index.
- Reliance on the performance of the underlying index.
- No dividend yield.
What Could Drive SCIU Stock Higher?
SCIU catalyst: Increasing investor interest in factor-based investing and smart beta strategies could drive demand for SCIU.
- Successful implementation of the EDHEC Risk Institute Asia Ltd.'s proprietary methodology could lead to outperformance and attract new investors.
- Potential for new partnerships with financial advisors and wealth management platforms to expand distribution channels (within the next 12 months).
What Are the Key Risks for SCIU?
Tracking error between the fund's performance and the underlying index could negatively impact investor returns.
- Changes in market conditions could negatively impact the performance of the underlying index.
- Competition from other factor-based ETFs could limit SCIU's growth potential.
- The fund's small market capitalization could lead to liquidity issues.
What Are the Growth Opportunities for SCIU?
- Increased Adoption of Factor-Based Investing: The growing awareness and acceptance of factor-based investing strategies among institutional and retail investors present a significant growth opportunity for SCIU. As investors seek to enhance portfolio diversification and risk-adjusted returns, the demand for ETFs like SCIU, which offer exposure to multiple factors, is likely to increase. The market size for factor-based ETFs is projected to reach $1 trillion by 2028, providing a substantial runway for growth.
- Expansion of Distribution Channels: SCIU can expand its reach by establishing partnerships with financial advisors, wealth management platforms, and online brokerage firms. By increasing its visibility and accessibility to a wider audience, SCIU can attract new investors and grow its assets under management (AUM). This expansion can be achieved through targeted marketing campaigns, educational resources, and participation in industry events. The timeline for this growth opportunity is ongoing, with continuous efforts to broaden distribution networks.
- Development of New Factor-Based Products: Global X can leverage its expertise in factor-based investing to develop new ETFs that target specific factors or combinations of factors. By offering a suite of differentiated products, Global X can cater to the diverse needs and preferences of investors. For example, the company could launch an ETF that focuses on a specific sector or industry while incorporating factor-based strategies. The timeline for launching new products is typically 12-18 months per ETF.
- Strategic Partnerships with Institutional Investors: Collaborating with institutional investors, such as pension funds and endowments, can provide SCIU with a stable source of capital and enhance its credibility. By offering customized investment solutions and tailored reporting, SCIU can attract large institutional mandates. These partnerships can also lead to increased brand awareness and recognition within the investment community. The timeline for securing strategic partnerships is typically 6-12 months per partnership.
- Geographic Expansion: While SCIU currently focuses on the U.S. equity market, Global X can explore opportunities to expand its factor-based investing strategies to other geographic regions. By launching ETFs that track international indexes or target specific countries, Global X can diversify its product offerings and tap into new markets. This expansion can be achieved through partnerships with local asset managers or by establishing a presence in key international financial centers. The timeline for geographic expansion is typically 2-3 years per region.
What Are SCIU's Competitive Advantages?
- Proprietary Index Methodology: The fund's underlying index is based on a proprietary methodology developed by EDHEC Risk Institute Asia Ltd., providing a unique approach to factor-based investing.
- Low Expense Ratio: The fund's expense ratio is competitive compared to other factor-based ETFs, attracting cost-conscious investors.
- Established Brand: Global X is a well-known and respected ETF provider, enhancing investor confidence.
What Does SCIU Do?
Global X Scientific Beta US ETF (SCIU) is designed to provide investment results that closely correspond to the price and yield performance of the Scientific Beta United States Multi-Beta Multi-Strategy Four-Factor Equal Risk Contribution (ERC) Index, before accounting for fees and expenses. The ETF was created to offer investors a strategic approach to accessing the U.S. equity market through a multi-factor lens. The fund achieves this by investing at least 80% of its total assets in the securities that comprise the underlying index. The underlying index is constructed using a proprietary methodology developed by EDHEC Risk Institute Asia Ltd., a research institute specializing in quantitative finance. This methodology selects approximately 500 or fewer U.S.-listed common stocks, aiming to capture a diversified portfolio that balances exposure across multiple factors. The ERC component of the index name indicates that the methodology seeks to equalize the risk contribution from each factor, potentially leading to a more stable and diversified investment outcome. SCIU offers investors a way to gain exposure to a sophisticated, research-driven approach to U.S. equity investing, potentially enhancing portfolio diversification and risk-adjusted returns. As of 2026, the fund continues to operate with the same investment objective and strategy, providing a consistent approach to factor-based investing.
What Products and Services Does SCIU Offer?
- Tracks the Scientific Beta United States Multi-Beta Multi-Strategy Four-Factor Equal Risk Contribution (ERC) Index.
- Invests at least 80% of its assets in securities of the underlying index.
- Provides exposure to approximately 500 U.S.-listed common stocks.
- Utilizes a proprietary methodology developed by EDHEC Risk Institute Asia Ltd.
- Offers a multi-factor investment strategy.
- Seeks to equalize the risk contribution from each factor.
- Aims to provide investment results that correspond to the price and yield performance of the index.
How Does SCIU Make Money?
- Generates revenue through management fees charged on assets under management (AUM).
- Aims to attract and retain investors by providing competitive returns and diversification benefits.
- Utilizes a passive investment strategy, minimizing trading costs and expenses.
What Industry Does SCIU Operate In?
The asset management industry is characterized by a wide range of investment strategies, including passive indexing, active management, and factor-based investing. SCIU operates within the factor-based investing segment, also known as smart beta. This segment has seen increasing popularity as investors seek to enhance returns and manage risk more effectively than traditional market-cap weighted indexes. Competitors in this space include ETFs and mutual funds offering exposure to similar factor-based strategies. The industry is also influenced by regulatory changes, technological advancements, and evolving investor preferences.
Who Are SCIU's Key Customers?
- Retail investors seeking diversified exposure to the U.S. equity market.
- Financial advisors looking for cost-effective factor-based investment solutions.
- Institutional investors seeking to enhance portfolio diversification and risk-adjusted returns.
SCIU Valuation & Market Position
With a $26.4M market cap, Global X Scientific Beta US ETF sits in the micro-cap segment of the market.
Key Financial Metrics
Return on equity for Global X Scientific Beta US ETF stands at 0.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.0%, showing how much profit it generates from its asset base. SCIU trades at a trailing price-to-earnings ratio of 0.00, below the Financial Services sector average of ~18x. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 0.0%, the inverse of the P/E and a quick read on earnings relative to price.
SCIU Financials
Bull Case vs Bear Case
Bull Case
- Diversified exposure to approximately 500 U.S.-listed stocks.
- Proprietary index methodology developed by EDHEC Risk Institute Asia Ltd.
- Competitive expense ratio.
- Established brand name (Global X).
Bear Case
- Small market capitalization ($0.03 billion).
- Potential for tracking error between the fund's performance and the underlying index.
- Reliance on the performance of the underlying index.
- No dividend yield.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
SCIU Latest News
No recent news available for SCIU.
SCIU Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for SCIU.
Price Targets
Wall Street price target analysis for SCIU.
SCIU MoonshotScore
What does this score mean?
The MoonshotScore rates SCIU 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Common Questions About SCIU (Financial Services)
What does Global X Scientific Beta US ETF do?
Global X Scientific Beta US ETF (SCIU) seeks to replicate the performance of the Scientific Beta United States Multi-Beta Multi-Strategy Four-Factor Equal Risk Contribution (ERC) Index. It invests primarily in U.S.-listed common stocks selected based on a proprietary methodology developed by EDHEC Risk Institute Asia Ltd.
What are the main risks for SCIU?
The main risks for SCIU include tracking error, which is the potential for the fund's performance to deviate from the underlying index. Market risk, which is the risk that changes in market conditions could negatively impact the performance of the underlying index. Competition risk, which is the risk that competition from other factor-based ETFs could limit SCIU's growth potential.
What are the key factors to evaluate for SCIU?
Evaluate SCIU on fundamentals, analyst consensus, and risk factors. Global X Scientific Beta US ETF (SCIU), with a market capitalization of $26.4M and a beta of 1.01, offers exposure to a multi-factor investment strategy within the U.S. Not financial advice.
How frequently does SCIU data refresh on this page?
SCIU's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven SCIU's recent stock price performance?
Global X Scientific Beta US ETF (SCIU) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified exposure to approximately 500 U.S.-listed stocks. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider SCIU overvalued or undervalued right now?
Global X Scientific Beta US ETF (SCIU) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research SCIU before investing?
Before investing in Global X Scientific Beta US ETF (SCIU), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding SCIU to a portfolio?
Key strength of Global X Scientific Beta US ETF (SCIU): Diversified exposure to approximately 500 U.S.-listed stocks. Weigh rewards against risks and diversify. Not financial advice.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- AI analysis is pending for SCIU, limiting the depth of available insights.
- The fund's performance is dependent on the success of the EDHEC Risk Institute Asia Ltd.'s proprietary methodology.